These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
402 related items for PubMed ID: 30850916
21. Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection Fraction. Santos AB, Roca GQ, Claggett B, Sweitzer NK, Shah SJ, Anand IS, Fang JC, Zile MR, Pitt B, Solomon SD, Shah AM. Circ Heart Fail; 2016 Apr; 9(4):e002763. PubMed ID: 27056882 [Abstract] [Full Text] [Related]
22. Effects of dipeptidyl peptidase-4 inhibitors on cardiac and endothelial function in type 2 diabetes mellitus: A pilot study. Leung M, Leung DY, Wong VW. Diab Vasc Dis Res; 2016 May; 13(3):236-43. PubMed ID: 26993495 [Abstract] [Full Text] [Related]
23. Long-Term Safety and Efficacy of Teneligliptin in Elderly Patients with Type 2 Diabetes: Subgroup Analysis of a 3-Year Post-Marketing Surveillance in Japan. Kadowaki T, Haneda M, Ito H, Sasaki K, Yamada Y. Adv Ther; 2020 May; 37(5):2477-2492. PubMed ID: 32323194 [Abstract] [Full Text] [Related]
24. Effect of switching to teneligliptin from other dipeptidyl peptidase-4 inhibitors on glucose control and renoprotection in type 2 diabetes patients with diabetic kidney disease. Kitada M, Ogura Y, Nitta K, Fujii M, Kanasaki K, Konishi K, Iida Y, Nakagawa A, Koya D. J Diabetes Investig; 2019 May; 10(3):706-713. PubMed ID: 30136384 [Abstract] [Full Text] [Related]
25. Longitudinal Changes in Cardiac Structure and Function From Adolescence to Young Adulthood in Participants With Type 2 Diabetes Mellitus: The TODAY Follow-Up Study. TODAY Study Group. Circ Heart Fail; 2020 Jun; 13(6):e006685. PubMed ID: 32498621 [Abstract] [Full Text] [Related]
29. Incremental prognostic value of global longitudinal strain in patients with type 2 diabetes mellitus. Liu JH, Chen Y, Yuen M, Zhen Z, Chan CW, Lam KS, Tse HF, Yiu KH. Cardiovasc Diabetol; 2016 Feb 03; 15():22. PubMed ID: 26842466 [Abstract] [Full Text] [Related]
30. Teneligliptin Prevents Cardiomyocyte Hypertrophy, Fibrosis, and Development of Hypertensive Heart Failure in Dahl Salt-Sensitive Rats. Yamamoto M, Ishizu T, Seo Y, Suto Y, Sai S, Xu D, Murakoshi N, Kimura T, Kawakami Y, Aonuma K. J Card Fail; 2018 Jan 03; 24(1):53-60. PubMed ID: 28888840 [Abstract] [Full Text] [Related]
31. Improved glycemic control with teneligliptin in patients with type 2 diabetes mellitus on hemodialysis: Evaluation by continuous glucose monitoring. Wada N, Mori K, Nakagawa C, Sawa J, Kumeda Y, Shoji T, Emoto M, Inaba M. J Diabetes Complications; 2015 Jan 03; 29(8):1310-3. PubMed ID: 26298521 [Abstract] [Full Text] [Related]
35. Effects of once-daily teneligliptin on 24-h blood glucose control and safety in Japanese patients with type 2 diabetes mellitus: a 4-week, randomized, double-blind, placebo-controlled trial. Eto T, Inoue S, Kadowaki T. Diabetes Obes Metab; 2012 Nov 03; 14(11):1040-6. PubMed ID: 22776014 [Abstract] [Full Text] [Related]
37. Fasudil improves short-term echocardiographic parameters of diastolic function in patients with type 2 diabetes with preserved left ventricular ejection fraction: a pilot study. Guo R, Su Y, Yan J, Sun H, Wu J, Liu W, Xu Y. Heart Vessels; 2015 Jan 03; 30(1):89-97. PubMed ID: 24390764 [Abstract] [Full Text] [Related]
39. Impact of diabetes mellitus on left ventricular longitudinal function of patients with non-ischemic dilated cardiomyopathy. Tanaka H, Tatsumi K, Matsuzoe H, Matsumoto K, Hirata KI. Cardiovasc Diabetol; 2020 Jun 13; 19(1):84. PubMed ID: 32534593 [Abstract] [Full Text] [Related]
40. The relationship between heart rate variability and left ventricular layer-specific deformation in uncomplicated diabetic patients. Vukomanovic V, Tadic M, Suzic-Lazic J, Kocijancic V, Celic V. Int J Cardiovasc Imaging; 2017 Apr 13; 33(4):481-490. PubMed ID: 27853970 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]